Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF Stock Price, Quotes and Forecasts
THNRARCA
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
3.87M
Fund Score
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF Price, Quotes and Forecasts | ARCA:THNR | Benzinga
Explore Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for THNR.
| Open | - |
| High | - |
| 52 Wk High | $28.19 |
| AUM | 3.87M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $304.13B |
| Mgmt Fee | 0.59% |
| P/E Ratio | 32.35 |
| Prev. Close | $21.16 |
| Low | - |
| 52 Wk Low | $21.08 |
| Shares Out | 180.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 929.00 |
| Beta | 0.71 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | 5.68 |
Recent News
FAQ
Q
How do I buy Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
You can purchase shares of Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
Q
Who are Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) competitors?
A
There are no as such competitors for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
Q
What is the forecast, or price target, for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
There is no analysis for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
Q
What is the current price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR)?
A
The stock price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $21.1624 last updated April 1, 2025 at 8:00 PM EDT.
Q
Does Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) pay a dividend?
A
A quarterly cash dividend of 0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on December 31, 2024 to stockholders of record on December 30, 2024.
Q
When is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) reporting earnings?
A
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
Q
Is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) going to split?
A
There is no upcoming split for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
| Open | - |
| High | - |
| 52 Wk High | $28.19 |
| AUM | 3.87M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | - |
| Market Cap | $304.13B |
| Mgmt Fee | 0.59% |
| P/E Ratio | 32.35 |
| Prev. Close | $21.16 |
| Low | - |
| 52 Wk Low | $21.08 |
| Shares Out | 180.00K |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 929.00 |
| Beta | 0.71 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | 5.68 |
About Amplify ETF Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Short Term Safe |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | Ernesto Tong Dustin Lewellyn |
| Definition | Fixed income fund portfolio contains a large percentage of securities with low duration and superior credit quality |
Investment Policy
The Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the Index. VettaFi LLC, a wholly-owned subsidiary of TMX Group Limited developed and maintains the Index (the Index Provider).
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved